novo-nordisk a/s-spons adr
(NVO:New York)
Key News About novo-nordisk a/s-spons adr
| Recently Viewed | |||
| NVO:US | $168.92 USD | -0.63 | |
| Company | Last | Change |
| AstraZeneca PLC | 3,427 GBp | -59.00 |
| Bristol-Myers Squibb Co | $47.00 USD | +0.60 |
| Eli Lilly & Co | $54.74 USD | -0.18 |
| Reckitt Benckiser Group PLC | 4,869 GBp | -57.00 |
| Takeda Pharmaceutical Co Ltd | ¥4,800 JPY | 0.00 |
| View Industry Companies | ||
Industry Analysis
NVO
Industry Average
| Valuation | NVO | Industry Range |
| Price/Earnings | 24.0x |
|
| Price/Sales | 6.7x |
|
| Price/Book | 16.0x |
|
| Price/Cash Flow | 19.4x |
|
| TEV/Sales | 5.3x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact NOVO-NORDISK A/S-SPONS ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








